Mmegi

Pharmaceuticals present $190m opportunity for growth, innovation

Shot in the arm: The COVID-19 pandemic exposed the need for countries such as Botswana to bulk up their pharmaceutical sectors PIC:  VCU NEWS
Shot in the arm: The COVID-19 pandemic exposed the need for countries such as Botswana to bulk up their pharmaceutical sectors PIC: VCU NEWS

A study into the potential of developing a pharmaceutical industry in the country has found that strategic investments in policy, skills development, and harnessing the country’s rich biodiversity, could transform the infant sector into a regional powerhouse.

The study was developed last year by the Botswana Investment and Trade Centre (BITC) in partnership with the European Union’s Africa RISE (Reform for Investment and Sustainable Economies) programme.

The study aims to help Botswana develop its pharmaceutical manufacturing capabilities while boosting its competitiveness at both local and regional levels. The consultancy team included three local experts from the University of Botswana who worked alongside the BITC team, reporting to a diverse reference group that validated the findings.

Editor's Comment
Makgekgenene played her part

“Ignore the noise, focus on your work”- AnonymousAs the DG of such a controversy-ridden institution, you really played your part in the fight against corruption and economic crime. Your stay at the helm of the DCEC was quickly paying dividends under your stewardship. During your tenure, there was a lot of action as those caught on the wrong side of the law were brought to court regardless of their economic or political status. We have learnt...

Have a Story? Send Us a tip
arrow up